HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.

Abstract

Orally bioavailable CXCR4 and CCR5 coreceptor antagonists are being developed for the treatment of HIV-1 infection. A new tropism-testing platform, which offers various options depending on the needs, was established. Each option has specific characteristics in terms of sensitivity, information, throughput and cost. The platform consists of four assays, all… (More)

Topics

Cite this paper

@article{Baelen2007HIV1CU, title={HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.}, author={Kurt Van Baelen and Ina I. Vandenbroucke and Evelien Rondelez and Veerle van Eygen and Hans Vermeiren and Lieven J. Stuyver}, journal={Journal of virological methods}, year={2007}, volume={146 1-2}, pages={61-73} }